Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1970 2
1973 1
1974 1
1975 1
1980 1
1986 1
2002 1
2003 2
2004 3
2005 1
2006 3
2007 1
2009 2
2011 5
2012 3
2013 1
2014 2
2015 4
2016 3
2017 4
2018 3
2019 1
2020 1
2021 1
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Primary squamous cell carcinoma of the parotid gland: clinicopathological characteristics, treatment, and prognosis.
Xiao M, Liu J, You Y, Yang X, Wang Y. Xiao M, et al. Int J Oral Maxillofac Surg. 2021 Feb;50(2):151-157. doi: 10.1016/j.ijom.2020.06.010. Epub 2020 Jul 4. Int J Oral Maxillofac Surg. 2021. PMID: 32631631
Squamous cell carcinoma (SCC) of the parotid gland is a rare aggressive malignancy with a poor prognosis. ...Great efforts have been made over the past two decades to identify and treat parotid SCC. Consensus regarding therapeutic …
Squamous cell carcinoma (SCC) of the parotid gland is a rare aggressive malignancy with a poor prognosis. …
Metastatic cutaneous squamous cell carcinoma to the parotid: Adjuvant radiotherapy and treatment outcomes.
Hu M, Kim ANH, Emeto TI, Collins M, Chopping A, Lin C. Hu M, et al. J Med Radiat Sci. 2023 Jun;70(2):161-170. doi: 10.1002/jmrs.650. Epub 2023 Feb 15. J Med Radiat Sci. 2023. PMID: 36790039 Free PMC article.
INTRODUCTION: Adjuvant radiotherapy is an established component in the management of metastatic cutaneous squamous cell carcinoma (SCC) involving the parotid gland. Radiotherapy technique, dose and volumes are seldom described sufficiently to al …
INTRODUCTION: Adjuvant radiotherapy is an established component in the management of metastatic cutaneous squamous cell car …
Mid-treatment 18F-FDG PET imaging changes in parotid gland correlates to radiation-induced xerostomia.
Trada Y, Lee MT, Jameson MG, Chlap P, Keall P, Moses D, Lin P, Fowler A. Trada Y, et al. Radiother Oncol. 2023 Sep;186:109745. doi: 10.1016/j.radonc.2023.109745. Epub 2023 Jun 15. Radiother Oncol. 2023. PMID: 37330056
BACKGROUND: The aim of this study was to measure functional changes in parotid glands using mid-treatment FDG-PET/CT and correlate early imaging changes to subsequent xerostomia in mucosal head and neck squamous cell carcinoma patients undergoing radio …
BACKGROUND: The aim of this study was to measure functional changes in parotid glands using mid-treatment FDG-PET/CT and correlate ea …
Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck.
D'Souza J, Clark J. D'Souza J, et al. Curr Opin Otolaryngol Head Neck Surg. 2011 Apr;19(2):99-105. doi: 10.1097/MOO.0b013e328343e811. Curr Opin Otolaryngol Head Neck Surg. 2011. PMID: 21297477 Review.
PURPOSE OF REVIEW: This article reviews the predictors, prognosis, and treatment of nodal metastases in cutaneous squamous cell carcinoma of the head and neck. RECENT FINDINGS: There is a better understanding of the risk factors that predict metastatic diseas …
PURPOSE OF REVIEW: This article reviews the predictors, prognosis, and treatment of nodal metastases in cutaneous squamous cell …
Submandibular gland cancer: Specific features and treatment considerations.
Aro K, Tarkkanen J, Saat R, Saarilahti K, Mäkitie A, Atula T. Aro K, et al. Head Neck. 2018 Jan;40(1):154-162. doi: 10.1002/hed.24981. Epub 2017 Oct 30. Head Neck. 2018. PMID: 29083518
BACKGROUND: In the absence of unified treatment protocol, we evaluated the management and outcomes of submandibular gland cancers in an unselected patient series. METHODS: We included all patients with resected submandibular gland cancer treated at the Helsinki Univ …
BACKGROUND: In the absence of unified treatment protocol, we evaluated the management and outcomes of submandibular gland cancers in …
Clinical management for T1 and T2 external auditory canal cancer.
Shinomiya H, Uehara N, Teshima M, Kakigi A, Otsuki N, Nibu KI. Shinomiya H, et al. Auris Nasus Larynx. 2019 Oct;46(5):785-789. doi: 10.1016/j.anl.2019.02.004. Epub 2019 Feb 21. Auris Nasus Larynx. 2019. PMID: 30799138
OBJECTIVE: The purpose of this study was to clarify the impact of superficial parotidectomy and postoperative radiotherapy (PORT) for the surgical treatment of early stage squamous cell carcinoma (SCC) in external auditory canal (EAC). MATERIALS AND METHODS: …
OBJECTIVE: The purpose of this study was to clarify the impact of superficial parotidectomy and postoperative radiotherapy (PORT) for the su …
Metastases to the parotid gland - A review of the clinicopathological evolution, molecular mechanisms and management.
Badlani J, Gupta R, Smith J, Ashford B, Ch'ng S, Veness M, Clark J. Badlani J, et al. Surg Oncol. 2018 Mar;27(1):44-53. doi: 10.1016/j.suronc.2017.11.007. Epub 2017 Dec 2. Surg Oncol. 2018. PMID: 29549903 Review.
Metastases to the parotid gland are the commonest cause of parotid malignancies in many regions of the world including Australia. The most common etiology of these metastases is head and neck cutaneous squamous cell carcinoma (HNcSCC) fol …
Metastases to the parotid gland are the commonest cause of parotid malignancies in many regions of the world including …
Management of the parotid for high-risk cutaneous squamous cell carcinoma: A review from the salivary section of the American Head and Neck Society.
Kejner AE, Harris BN, Patel R, McMullen C, Weir J, Dahshan BA, Carroll WR, Gillespie MB. Kejner AE, et al. Am J Otolaryngol. 2022 Mar-Apr;43(2):103374. doi: 10.1016/j.amjoto.2022.103374. Epub 2022 Feb 2. Am J Otolaryngol. 2022. PMID: 35158264 Review.
BACKGROUND: Metastases to the parotid nodal basin in patients with high-risk cutaneous squamous cell carcinoma (HRcSCC) impact disease specific survival (DSS) and overall survival (OS). ...CONCLUSIONS: This clinical update represents contemporary optim …
BACKGROUND: Metastases to the parotid nodal basin in patients with high-risk cutaneous squamous cell carcinoma ( …
Differential diagnosis of parotid gland tumours: which magnetic resonance findings should be taken in account?
Tartaglione T, Botto A, Sciandra M, Gaudino S, Danieli L, Parrilla C, Paludetti G, Colosimo C. Tartaglione T, et al. Acta Otorhinolaryngol Ital. 2015 Oct;35(5):314-20. doi: 10.14639/0392-100X-693. Acta Otorhinolaryngol Ital. 2015. PMID: 26824912 Free PMC article.
Our aim was to define typical magnetic resonance (MRI) findings in malignant and benign parotid tumours. This study is based on retrospective evaluation of pre-surgical MRI of 94 patients with parotid gland tumours. ...There were 69 cases of benign (73%) and …
Our aim was to define typical magnetic resonance (MRI) findings in malignant and benign parotid tumours. This study is based on retro …
Management of parotid gland neoplasms.
Biörklund A, Eneroth CM. Biörklund A, et al. Am J Otolaryngol. 1980 Feb;1(2):155-67. doi: 10.1016/s0196-0709(80)80011-1. Am J Otolaryngol. 1980. PMID: 6255810 Review.
This clinical review presents a survey of the different types of epithelial neoplasms in the parotid gland. The incidence, histopathological classification, grade of malignancy, and staging system are discussed. Diagnostic procedures are reviewed and a scheme for tr …
This clinical review presents a survey of the different types of epithelial neoplasms in the parotid gland. The incidence, his …
46 results